Simon J. Thomas

London, ENG W127FP, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Antibody format matters: A comparative analysis of VHH and scFv domains reveals superior in vivo CAR T cell function with VHH domains.

Antibody format matters: A comparative analysis of VHH and scFv domains reveals superior in vivo CAR T cell function with VHH domains.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 04, 2025

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.

Journal: Cancer cell

Published: September 01, 2025

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Journal: Nature medicine

Published: August 12, 2025

Gut dysbiosis in oncology: a risk factor for immunoresistance.

Gut dysbiosis in oncology: a risk factor for immunoresistance.

Journal: Cell research

Published: June 27, 2025

The Effect of Pre-Bending Flexible Nails on Outcomes Following Stabilization of Paediatric Forearm Fractures.

The Effect of Pre-Bending Flexible Nails on Outcomes Following Stabilization of Paediatric Forearm Fractures.

Journal: Journal of pediatric orthopedics

Published: June 25, 2025

Microbiota-centered interventions to boost immune checkpoint blockade therapies.

Microbiota-centered interventions to boost immune checkpoint blockade therapies.

Journal: The Journal of experimental medicine

Published: February 24, 2025

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.

Journal: Nature communications

Published: October 13, 2024

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

Journal: American journal of human genetics

Published: August 27, 2024

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.

Journal: Cancer cell

Published: January 27, 2024

Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.

Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.

Journal: ACS chemical biology

Published: January 20, 2024

TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Journal: Nature medicine

Published: January 18, 2024

Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.

Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 16, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026